UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 683

Sortiert nach

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Diabetes, obesity & metabolism, 2011, Vol.13 (1), p.65-74

2011

Link zum Volltext

Verfügbarkeit prüfen

Diabetic dyslipidaemia: from basic research to clinical practice

Diabetologia, 2003-06, Vol.46 (6), p.733-749

TASKINEN, M.-R

2003

Link zum Volltext

Verfügbarkeit prüfen

Ectopic lipid storage and insulin resistance: a harmful relationship

Journal of internal medicine, 2013-07, Vol.274 (1), p.25-40

2013

Link zum Volltext

Verfügbarkeit prüfen

Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes

Journal of internal medicine, 2021-09, Vol.290 (3), p.632-645

2021

Link zum Volltext

Verfügbarkeit prüfen

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics

Journal of internal medicine, 2019-05, Vol.285 (5), p.562-577

2019

Link zum Volltext

Verfügbarkeit prüfen

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Diabetologia, 2006-09, Vol.49 (9), p.2049-2057

2006

Link zum Volltext

Verfügbarkeit prüfen

Overproduction of large VLDL particles is driven by increased liver fat content in man

Diabetologia, 2006-04, Vol.49 (4), p.755-765

2006

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

Journal of internal medicine, 2020-10, Vol.288 (4), p.422-438

2020

Link zum Volltext

Verfügbarkeit prüfen

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

Diabetologia, 2012-04, Vol.55 (4), p.915-925

2012

Link zum Volltext

Verfügbarkeit prüfen

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Diabetologia, 2009-04, Vol.52 (4), p.684-690

2009

Link zum Volltext

Verfügbarkeit prüfen

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study

Diabetologia, 2011-11, Vol.54 (11), p.2811-2819

2011

Link zum Volltext

Verfügbarkeit prüfen

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2011-04, Vol.13 (4), p.374-377

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

The Lancet (British edition), 2007-11, Vol.370 (9600), p.1687-1697

2007

Link zum Volltext

Verfügbarkeit prüfen

Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity

Journal of internal medicine, 2017-08, Vol.282 (2), p.187-201

2017

Link zum Volltext

Verfügbarkeit prüfen

Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate – Authors’ response

Journal of internal medicine, 2020-01, Vol.287 (1), p.118-118

2020

Link zum Volltext

Verfügbarkeit prüfen

The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes

Diabetic medicine, 2013-06, Vol.30 (6), p.756-757

2013

Link zum Volltext

Verfügbarkeit prüfen

Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes

Journal of internal medicine, 2017-06, Vol.281 (6), p.586-600

2017

Link zum Volltext

Verfügbarkeit prüfen

Kinetic studies to investigate lipoprotein metabolism

Journal of internal medicine, 2012-02, Vol.271 (2), p.166-173

2012

Link zum Volltext

Verfügbarkeit prüfen

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

Diabetes, obesity & metabolism, 2014-06, Vol.16 (6), p.560-568

2014

Link zum Volltext

Verfügbarkeit prüfen

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

Diabetologia, 2010-09, Vol.53 (9), p.1846-1855

2010

Link zum Volltext

Verfügbarkeit prüfen

A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population

Obesity (Silver Spring, Md.), 2013-10, Vol.21 (10), p.2138-2145

2013

Link zum Volltext

Verfügbarkeit prüfen

Deep subcutaneous adipose tissue is more saturated than superficial subcutaneous adipose tissue

International Journal of Obesity, 2013-04, Vol.37 (4), p.620-622

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week open-label extension

International journal of clinical practice (Esher), 2012-08, Vol.66 (8), p.731-740

2012

Link zum Volltext

Verfügbarkeit prüfen

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes

Diabetologia, 2009-12, Vol.52 (12), p.2522-2530

2009

Link zum Volltext

Verfügbarkeit prüfen

family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study

Diabetologia, 2010-08, Vol.53 (8), p.1709-1713

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 683

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(579)
Mit Volltextzugriff
(558)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(463)
Science & Technology
(439)
Life Sciences & Biomedicine
(414)
Male
(324)
Biological And Medical Sciences
(279)
Medical Sciences
(263)
Middle Aged
(262)
Female
(254)
Adult
(234)
Endocrinology & Metabolism
(140)
Triglycerides - Blood
(115)
Aged
(104)
Cardiovascular System & Cardiology
(100)
Endocrinopathies
(99)
Diabetes. Impaired Glucose Tolerance
(93)
Endocrine Pancreas. Apud Cells
(93)
Lipoproteins - Blood
(91)
Risk Factors
(80)
Cardiac & Cardiovascular Systems
(78)
Peripheral Vascular Disease
(77)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Diabetic dyslipidaemia: from basic research to clinical practice

Ectopic lipid storage and insulin resistance: a harmful relationship

Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Overproduction of large VLDL particles is driven by increased liver fat content in man

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity

Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate – Authors’ response

The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes

Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes

Kinetic studies to investigate lipoprotein metabolism

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population

Deep subcutaneous adipose tissue is more saturated than superficial subcutaneous adipose tissue

Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week open-label extension

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes

family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study

Suchergebnisse filtern